Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HEPRA: 14-day Quadruple vs Triple Therapy for H. pylori
NCT04769583Phase 4Completed
- Start
- Feb 2019
- Primary completion
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metronidazole in Helicobacter pylori infection. Started Feb 2019; status: completed.
02
Drugs
metronidazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04769583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04769583.